CVPR Week 4: Vascular smooth muscle and endothelial cells Flashcards
Application of ACh to vasculature will provoke this response
Dilation
What are the primary resistance vessels?
Arterioles
Arteriole function related to ‘primary resistance vessels’
2 listed

Identify


Identify + role of intrinsic and extrinsic factors


How is vascular tone mediated?
through smooth muscle contraction/relaxation
How is vascular tone regulated?
- Contraction can be initiated by chemical or electrical signals or both
- through intrinsic/extrinsic factors
- Sympathetic innervation

Spatial control of vasculature: Sympathetic nerves
effects the vasculature throughout the whole body
Spatial control of vasculature: Extrinsic factors
effects the vasculature throughout the whole body
Spatial control of vasculature: Intrinsic factors
Have a regional effect on vasculature
Examples of extrinisic factors of vascular control
Neurohumoral (i.e sympathetic activation)
circulating factors (i.e. hormones)
Neurohumoral activation description
refers to increased activity of the sympathetic nervous system, renin-angiotensin system, vasopressin and atrial natriuretic peptide.
Examples of intrinisic factors of vascular control
3 listed
- endothelial factors
- mechanical factors (i.e. flow and pressure)
- metabolites
Sympathetic activation of the vasculature
NE or EPI released and bound by α and β receptors causing smooth muscle contraction or dilation

EPI affinity deficit
EPI has a higher affinity for β2 receptor over α1 which would result in vasodilation over vasoconstriction
Low amounts of epi stimulate β2 over α1

Sympathetic activation of α1 receptors causes smooth muscle contraction in?
6 listed
- vasculature (all systemic vessels)
- eye
- bladder
- prostate
- uterus
However, in the GI tract α1 receptors causes relaxation
Stimulation of α1 receptors in this location causes relaxation
GI tract
Stimulation of α1 receptors in the GI tract causes?
smooth muscle relaxation
Sympathetic activation of β2 receptors causes
vasodilation (in vessels supplying skeletal muscle, liver and heart)
and relaxation of
- Eye
- Bronchioles
- Bladder
- Uterus
- GI Tract
At low concentrations of EPI you will see what response in the vasculature?
Vasodilation
At high concentrations of EPI you will see what response in the vasculature?
Vasoconstriction (due to the increased activation of α1 receptors
Objectives

Identify


Excitation-contraction coupling in skeletal muscle
electrical volatage causes confirmational change in the Dihydropyridine receptor which is physically inked to the ryanodine receptor which opens the ryandoine receptor and releases from the sarcoplasmic reticulum

Excitation-contraction coupling in cardiac muscle
- Calcium-induced calcium release through the stimulation of L-type voltage-gated Ca2+ channel (L-type VGCCs) through an SA nodal action potential and Ca2+ is brought into the cell and activates the Ryanodine receptor which is not physically linked to release more Ca2+ from the Sarcoplasmic reticulum
- Can be modulated by EPI or NE through (Gs coupled receptors) linked to adenylate cyclase which stimulate it to increase cAMP to further increase CICR from the SR and voltage-gated Ca2+ receptors in the cell membrane and increasing HR and contractility
- Can also be modulated by ACh through Gi coupled receptors which inhibit adenylate cyclase and decrease Ca2+ release thereby decreasing cAMP, HR and contractility

Explain the differences in excitation-contraction coupling in skeletal muscle versus cardiac muscle

Excitation-contraction coupling in smooth muscle
- Similar to cardiac muscle through the use of voltage-dated Ca 2+ L-type Channels (VGCCs L-type) opening as a result of an action potential and stimulation of non-physically linked ryanodine receptor to release Ca2+ from the sarcoplasmic reticulum
However, the main difference is through receptor coupling in the form of PlP2 Gq coupled noradrenergic (α 1) receptors which are activated by NE and EPI and take Phospholipase C into DAG and IP3
- IP3 channels also further increase Ca2+ release
- So you have ryanodine receptors as well as IP3Rs on the SR
- And activation of DAG results in the activation of PKC which stimulates opening of ROC channels (Receptor-operated channels) which are non-selective for Na+/Ca2+, where the Ca2+ contributes further to CICR and the Na+ further contributes to membrane depolarization

Gq PCR agonists
6 listed
- NE/EPI
- Endothelin 1
- Thromboxane A2
- Vasopressin
- ACh

NE/EPI Gq PCR
α1 noradrenergic receptor
Angiotensin II Gq PCR
AT1
Endothelin I Gq PCR
2 listed
ETA/ETB
Thromboxane A2 Gq PCR
TXA2R
Vasopressin Gq PCR
V1
ACh Gq PCR
M3
ACh Gq PCR location
on non-vascular smooth muscle cells
Smooth muscle cells closing of K+ channels
will lead to depolarization of the cell
Similarities of actomyosin regulation of smooth and striated muscle cells
- Ca2+ is important for contraction
- Force is created by an actin-myosin crossbridge interaction between sliding filaments
Differences of actomyosin regulation of smooth and striated muscle cells
- the organization of actin-myosin filaments
- Ca2+ regulation of contraction
What gives rise to the striated appearance in skeletal and cardiac muscle?
the sarcomere functional unit

Sarcomere structural-functional relationship
2 listed
- contraction occurs in one direction
- limits the force and velocity of contraction
Sarcomeres in smooth muscle cellls
Smooth muscle cells lack sarcomeres

Identify


Contractile unit in smooth muscle cells
- Actin filaments are attached to dense bodies
- myosin filaments aren’t attached to anything but actin
- The actin-myosin contractile units are arranged in different directions
- can rearrange very rapidly
- maintain same amount of force on contraction but are added in series or parallel

Ca2+ in striated muscle

Smooth muscle Troponin
- smooth muscle cells don’t have troponin inhibiting actin
Instead,
- Ca2+ binds to calmodulin and this complex activates myosin like chain kinase (MLCK)
- MLCK phosphorylates myosin head and allows for contraction

Skeletal muscle contraction is dependent on?
Ca2+

Smooth muscle contraction is dependent on?
MLCK phosphorylation of the myosin head

In smooth muscle how is relaxation mediated?
6 listed
- MLCP (phosphatase) dephosphorylates the myosin head
- decrease cytosolic [Ca2+]
- open K+ leak channels to hyperpolarize the cell
- Inhibit MLCK
- cAMP
- cGMP

Cyclic molecules and smooth muscle
cAMP inhibits MLCK and reduce intracellular [Ca2+]
cAMP is produced by what interaction in smooth muscle
- EPI
- Prostacyclin
- Adenosine
Through Gs coupled receptors

cAMP effect on smooth muscle
inhibits MLCK and thereby reducing [Ca2+] inside the smooth muscle cell
cGMP effect on smooth muscle cells
- Activates MLCP thereby reducing intracellular [Ca2+]
- as well as other mechanisms of reducing [Ca2+] inside the cell

NO effect on GTP
converts GMP into cGMP through activation of sGC (soluble guanylyl cyclase)

Major stimulus converting GTP into cGMP in smooth muscle
NO (nitric oxide)

Particulate guanylyl cyclase description
instead of soluble in the cell is on the membrane and is activated by atrial natriuretic and brain natriuretic peptides

Particulate guanylyl cyclase is activated by?
activated by atrial natriuretic and brain natriuretic peptides

ANP AKA
Atrial natriuretic peptide
BNP AKA
Brain natriuretic peptide
Net effect of ANP and BMP on smooth muscle
Dilation

cAMP in smooth and cardiac muscle cells
causes relaxation in the vasculature and smooth muscle cells by inhibiting MLCK which is necessary for contraction
In cardiac cells cAMP is activating L-type VGCCs which is stimulatory toward contraction (increase HR and contractility)

Smooth muscle cells are well-suited for
tonic contraction (partial contraction)

Smooth muscle cell contraction speed
- slower than skeletal and cardiac muscle

Smooth muscle energy usage
use much less energy for the amount of force generated and maintained

Smooth muscle endurance
can sustain contractions for very long periods without becoming fatigued

Smooth muscle contraction is regulated by?
the phosphorylation of the myosin head

Smooth muscle contraction and membrane potential
contraction is not always associated with changes in membrane potential

Smooth muscle contractile unit arrangement
not arranged in sarcomeres which is an important feature which allows smooth muscle cells to undergo rearrangement with a constant force of contraction

Smooth muscle contraction and Ca2+s role
smooth muscle cells do not have troponin and use Ca2+ to regulate MLCK activation so it is indirectly linked to cross-bridge cycling by whether or not myosin is phosphorylated

Endothelial cell description
- is highly metabolically active
- is considered an organ
- with important endocrine and autocrine function that affect both underlying smooth muscle cells and other cells in the blood

Endothelial cell function
5 listed
- involved in leukocyte trafficking and inflammation
- involved in hemostasis
- serves in barrier function and permeability
- involved in smooth muscle cell homeostasis (keeps them quiescent and prevents unnecessary proliferation)
- involved in vascular tone and blood flow

Why do Endothelial cells need Ca2+ ?
- needed to produce the vasoactive products that are generated in the endothelium

Stimuli for Ca2+ change in endothelial cells
- mechanical stress (shear stress of laminar flow)
- Receptor activation (Gq coupled receptors)

Endothelial cells Ca2+ release mechanisms
- don’t have ryanodine receptors like muscle cells to stimulate release of Ca2+ from intracellular stores
- intracellular store release is through IP3 receptors
- don’t have VGCCs just have ROCs
ACh effect on smooth muscle
causes contraction of smooth muscle

ACh effect on eye
constricts the pupil (sphincter pupilae)
ACh effect on lungs
constrict bronchioles and increases secretion
ACh effect on heart
decreased HR
ACh effect on blood vessels
M3 not on the smooth muscle cells but on the endothelial cells
dilates (through release of NO)
ACh effect on GI
- increases peristalsis
- increases secretions
ACh effect on bladder
contraction for micturation
ACh effect on salivary glands
increased salivation
NO is produced where?
- by endothelial cells
- by endothelial nitric oxide synthase

endothelial nitric oxide synthase reaction
uses Oxygen and a cofactor to produce NO
converts L-arginine to L citrulline

Drugs that take advantage of NO’s dilation of the vasculature
want to increase NO production leading to the relaxation of vascular smooth muscle cells
- Arginase inhibitor to keep more substrate around
Directly stimulate vascular smooth muscle cells
- Inhaled NO
- Nitrates - nitroglycerin (angina) reduces hypoxia and helps blood flow in coronary vessels
- sGC activators
- inhibit PDE5 (prevents the breakdown of cGMP into GMP) VIAGRA!!!

Metabolites of arachidonic acid vasoactive metabolites
- Thromboxane A2
- prostacyclin (PGl2)
main Vasoactive metabolites of arachidonic acid
2 listed
- Thromboxane A2
- prostacyclin (PGl2)
Vasoactive metabolites of arachidonic acid activation mechanisms
- shear stress from laminar flow
- receptor activation (Ca2+ causes the activation of phospholipase A2 which releases stored arachidonic acid which was stored in membrane phospholipids
- once released can be metabolized into other active compounds (enzyme such as COX-1 and COX-2)
Prostacyclin effect on the vasculature
relaxation (through Gs coupled receptor increasing cAMP)

Thromboxane A2 effect on the vasculature
causes contraction (through Gq coupled PLC pathway)

Targets of arachidonic acid metabolites

Thromboxane A2 effect on platelets
- vasoconstriction
- platelet aggregation
- Thrombosis
Prostaglandins effect on gastric mucosa

Prostaglandins effect on joints

Prostacyclin effect on endothelial cells
- Vasodilation
- reduced platelet aggregation

NSAIDs inhibit?
COX-1&2
to try to prevent pain and inflammation and fever
side effects causes gastric ulcers

Corticosteroids inhibit
Phospholipase A2 (PLA2)

Selective COX-2 inhibitors
celebrex
however, increased risk of cardiovascular disease because reduced vasodilation

Know what COX inhibitors inhibit and what side effects they may have

Prostacyclin analogues

Endothelin-1 features
can act as a vasodilator or vasoconstrictor

Endothelin-1 production

Endothelin-1 paracrine autocrine
since there is a constant production of Endothelin-1 it can act as an autocrine factor

Endothelin-1 storage
stored in vesicles in the endothelial cells

Endothelin-1 function
can lead to production of NO and PGl2 leading to vascular relaxation and antihypertrophic effect on smooth muscle cells
Endothelin-1 circulating levels
these receptors take up excess Endothelin-1 and clears circulating levels
When there is a Endothelin-1 overproduction
Endothelin-1 acts in a paracrine fashion and binds directly to receptors on smooth muscle cells which will lead to contraction of smooth muscles (very potent vasoconstrictor when it reaches high levels, also proliferative as well)

Endothelin-1 smooth muscle receptors
ETA and ETB

Selective ETA and ETB inhibitors

Angiotensin II description
a potent vasoconstrictor
Angiotensin II production
- Angiotensinogen produced in the liver and goes into circulation
- converted to Angiotensin I by renin which is produced by the juxtaglomerular cells of the kidney
- converted to angiotensin II by ACE enzyme

ACE location & function
3 listed
- ACE is lovated on the endothelial cells and Ang II leads to contraction
- ACE breaks down bradykinin which could have caused vasodilation
- so ACE contributes to contraction by Ang II and through breakdown of bradykinin

ACE inhibitor function
inhibits ACE preventing
- Angiotensin I conversion to Angiotensin II
- the breakdown of bradykinin

AT1 blocker function
blocks angiotensin II receptors preventing the vasoconstriction

The important roles of endothelial factors
Prostacyclin & NO - anti-inflammatory and anti-thrombotic, NO is for relaxation Prostacyclin is antihypertrophic
Thromboxane and Endothelin-1 - pro-inflammatory and prothrombotic, ET1 is vasoconstriction, TXA2 is mitogenic causing remodeling of the vascular wall

An important trigger for endothelial dysfunction
oxidative stress

How does oxidative stress cause endothelial dysfunction?
all of these things shift the endothelium from producing healthy protective factors but it produces more of the harmful factors

Onset of endothelial dysfunction
insidious onset over a long time
want to test early on for endothelial function

Tests of endothelial function
4 listed

Invasive tests of endothelial function
2 listed

ACE location
ACE is loCated on the endothelial cells and Ang II leads to contraction
ACE function
ACE breaks down bradykinin which could have caused vasodilation
ACE Effects
ACE contributes to vascular smooth muscle contraction by Ang II and through the breakdown of bradykinin
Non-Invasive tests of endothelial function
2 listed

Endothelial dysfunction results in?
reduced responsiveness to ACh and prevents dilation like they shoud

Treatments of endothelial dysfunction
5 listed
- diet and exercise (REALLY GOOD)
- ACE
- nitrate therapy
- lipid-lowering drugs
- alpha-beta blockers

Vascular sensitivity to atherosclerotic lesions
- occur at curves or bifurcations because of the disturbed flow causing decreased expression of COX-2 and ENOS (produces NO)
- so these areas are more prone
- shows how shear stress is very important for a function endothelium

Role of endothelial cells in angiogensis

Vasculogenesis description
occurs from progenitor cells

Angiogenesis description
formation of new blood vessels from existing blood vessels
Normal angiogenesis causes
4 listed
- wound healing
- muscle mass increase
- acclimation to altitude
- pregnancy fetal supply

Pathogenic angiogenesis causes
- cancer
- stroke
- diabetes
- obesity
- heart disease
- multiple sclerosis
- Alzheimer’s DIsease
- Retinopathy
- Preeclampsia

Blood vessel growth regulation
- Hypoxia is a huge stimulus for the production of angiogenic growth factors
- however other things can too such as diabetes, retinopathy, cancer, etc

Cause of insufficient angiogenesis
3 listed
- Age
- low VEGF
- H. Pylori

refraction of the vasculature AKA
pruning of the vasculature

The most important mediator of angiogenesis
VEGF

Process of angiogenesis look over
- bind to receptors on endothelial cells
- migrate towards the source of VEGF
- HDL4 and NOTCH
- platelets come in through platelet-derived growth factor
Cells that initiate angiogenesis
Endothelial cells
Anti-VEGF therapies use
commonly used in cancer and other morbidities

Consequences of anti-VEGF therapy
- decreased vasodilator production NO PGl2
- increased vasoconstrictors
- microvascular refraction
- ROS oxidative stress
- Pressure naturesis
- decreased lymphangiogenesis
- all leads to vascular remodeling and increased peripheral resistance and volume overload
- 80-100% of patients on these therapies get hypertension and cardiovascular disease

Summary of angiogenesis

Question 1


Question 2


Question 3


Question 4


Question 5


Question 6

